Toxicologic Pathology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Free Full Text (Free PDF) Free
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morgan, K. T.
Right arrow Articles by Benavides, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morgan, K. T.
Right arrow Articles by Benavides, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Toxicologic Pathology, Vol. 30, No. 4, 435-451 (2002)
DOI: 10.1080/01926230290105613

Application of cDNA Microarray Technology to In Vitro Toxicology and the Selection of Genes for a Real-Time RT-PCR-Based Screen for Oxidative Stress in Hep-G2 Cells

Kevin T. Morgan

Aventis Pharmaceuticals, Raleigh, North Carolina, USA, kevin.morgan{at}aventis.com

Hong Ni

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

H. Roger Brown

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Lawrence Yoon

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Charles W. Qualls, JR

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Lynn M. Crosby

US Environmental Protection Agency, Research Triangle Park, North Carolina, USA

Randall Reynolds

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Betty Gaskill

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Steven P. Anderson

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Thomas B. Kepler

Santa Fe Institute, Santa Fe, New Mexico, USA

Tracy Brainard

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Nik Liv

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Marilyn Easton

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Christine Merrill

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Don Creech

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Dirk Sprenger

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Gary Conner

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Paul R. Johnson

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Tony Fox

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Maureen Sartor

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Erika Richard

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Sabu Kuruvilla

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Warren Casey

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Gina Benavides

GlaxoSmithKline, Inc, Research Triangle Park, North Carolina, USA

Large-scale analysis of gene expression using cDNA microarrays promises the rapid detection of the mode of toxicity for drugs and other chemicals. cDNA microarrays were used to examine chemically induced alterations of gene expression in HepG2 cells exposed to a diverse group of toxicants at an equitoxic exposure concentration. The treatments were ouabain (43 µM), lauryl sulfate (260 µ M), dimethylsulfoxide (1.28 M), cycloheximide (62.5 µM), tolbutamide (12.8 mM), sodium fluoride (3 mM), diethyl maleate (1.25 mM), buthionine sulfoximine (30 mM), potassium bromate (2.5 mM), sodium selenite (30 µM), alloxan (130 mM), adriamycin (40 µM), hydrogen peroxide (4 mM), and heat stress (45•C x 30 minutes). Patterns of gene expression were correlated with morphologic and biochemical indicators of toxicity. Gene expression responses were characteristically different for each treatment. Patterns of expression were consistent with cell cycle arrest, DNA damage, diminished protein synthesis, and oxidative stress. Based upon these results, we concluded that gene expression changes provide auseful indicator of oxidative stress, as assessed by the GSH:GSSG ratio. Under the conditions of this cell culture test system, oxidative stress upregulated 5 genes, HMOX1, p21waf1/cip1, GCLM, GR, TXNR1 while downregulating CYP1A1 and TOPO2A. Primers and probes for these genes were incorporated into the design of a 7-gene plate for RT-PCR. The plate design permitted statistical analysis and allowed clear discrimination between chemicals inducing oxidative vs nonoxidative stress. A simple oxidative stress score (0—1), based on the responses by the 7 genes (including p-value) on the RT-PCR plate, was correlated with the GSH:GSSG ratio using linear regression and ranking (Pearson product) procedures. These analyses yielded correlation coefficients of 0.74 and 0.87, respectively, for the treatments tested (when 1 outlier was excluded), indicating a good correlation between the biochemical and transcriptional measures of oxidative stress. We conclude that it is essential to measure the mechanism of interest directly in the test system being used when assessing gene expression as a tool for toxicology.

Tables 1—15, referenced in this paper, are not printed in this issue of Toxicologic Pathology. They are available as downloadable text files at http://taylorandfrancis.metapress.com/openurl.asp?genre=journal&issn=0192-6233. To access them, click on the issue link for 30(4), then select this article. A download option appears at the bottom of this abstract. In order to access the full article online, you must either have an individual subscription or a member subscription accessed through www.toxpath.org.

Key Words: Oxidative stress • GSH:GSSG • gene expression • cDNA arrays • RT-PCR • toxicity screen • Hep-G2 cells • transcriptomics.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
M. J. Liguori, E. A.G. Blomme, and J. F. Waring
Trovafloxacin-Induced Gene Expression Changes in Liver-Derived in Vitro Systems: Comparison of Primary Human Hepatocytes to HepG2 Cells
Drug Metab. Dispos., February 1, 2008; 36(2): 223 - 233.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. T. Morgan, M. Pino, L. M. Crosby, Min Wang, T. C. Elston, Z. Jayyosi, M. Bonnefoi, and G. Boorman
Complementary Roles for Toxicologic Pathology and Mathematics in Toxicogenomics, With Special Reference to Data Interpretation and Oscillatory Dynamics
Toxicol Pathol, January 1, 2004; 32(1_suppl): 13 - 25.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
K. T. Morgan, W. Casey, M. Easton, D. Creech, Hong Ni, L. Yoon, S. Anderson, C. W. Qualls JR, L. M. Crosby, A. Macpherson, et al.
Frequent Sampling Reveals Dynamic Responses by the Transcriptome to Routine Media Replacement in HepG2 Cells
Toxicol Pathol, June 1, 2003; 31(4): 448 - 461.
[Abstract] [PDF]